CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Finemedix Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Finemedix Co Ltd
Phone: +82 537418388p:+82 537418388 DAEGU, 704948  South Korea Fax: +82 537418168f:+82 537418168

Business Summary
Finemedix Co Ltd is a Korea-based company primarily engaged in the medical devices manufacturing and sales business. The Company mainly engages in the microinvasive medical devices such as therapeutic endoscopes and diagnostic endoscopes. The Company also provides endoscopic surgery devices such as knives, injectors, baskets, Endoscopic clips as well as snares for ESD (endoscopic submucosal dissection) and EMR (endoscopic mucosal resection).
(Source: N-30D)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

General Information
Outstanding Shares: 4,503,400 (As of 12/10/2024)
Fax Number: +82 537418168


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 21, 2024